Effects of fish oil supplementation on inflammatory acne

Lipids in Health and Disease

Thomas Spalding¹  Bonny Burns-Whitmore¹  Julia Young¹  Golandam Khayef¹ 

[1] Department of Human Nutrition and Food Science, California State Polytechnic University, Pomona, California, USA

关键词: EPA;    Omega 3 Fatty Acid;    n-3 Fatty Acid;    Inflammation;    Fish Oil;    Acne Vulgaris;   

Others  :  1160126
DOI  :  10.1186/1476-511X-11-165

 received in 2012-11-01, accepted in 2012-11-28,  发布年份 2012

【 摘 要 】

Background

Given that acne is a rare condition in societies with higher consumption of omega-3 (n-3) relative to omega-6 (n-6) fatty acids, supplementation with n-3 may suppress inflammatory cytokine production and thereby reduce acne severity.

Methods

13 individuals with inflammatory acne were given three grams of fish oil containing 930 mg of EPA to their unchanged diet and existing acne remedies for 12 weeks. Acne was assessed using an overall severity grading scale, total inflammatory lesion counts, and colorimetry.

Findings

There was no significant change in acne grading and inflammatory counts at week 12 compared to baseline. However, there was a broad range of response to the intervention on an individual basis. The results showed that acne severity improved in 8 individuals, worsened in 4, and remained unchanged in 1. Interestingly, among the individuals who showed improvement, 7 were classified as having moderate to severe acne at baseline, while 3 of the 4 whose acne deteriorated were classified as having mild acne.

Conclusion

There is some evidence that fish oil supplementation is associated with an improvement in overall acne severity, especially for individuals with moderate to severe acne. Divergent responses to fish oil in our pilot study indicates that dietary and supplemental lipids are worthy of further investigation in acne.

【 授权许可】

   
2012 Khayef et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton B, Brand-Miller J: Acne vulgaris: a disease of western civilization. Arch Dermatol 2002, 138:1584-1590.
• [2]Uhlenhake E, Yentzer BA, Feldman SR: Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2009, 9:59-63.
• [3]James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71:343S-348S.
• [4]Logan AC: Omega-3 fatty acids and acne. Arch Dermatol 2003, 139:941-943.
• [5]Bowe WP, Joshi SS, Shalita AR: Diet and acne. J Am Acad Dermatol 2010, 63:124-141.
• [6]Logan AC: Linoleic and linolenic acids and acne vulgaris. Br J Dermatol 2008, 158:201-202.
• [7]Jung JJ, Yoon MY, Min SU, Hong JS, Choi YS, Suh DH: The influence of dietary patterns on acne vulgaris in Koreans. Eur J Dermatol 2010, 20:768-772.
• [8]Di Landro A, Cazzaniga S, Parazzini F, Ingordo V, Cusano F, Atzori L, Cutri FT, Musumeci ML, Zinetti C, Pezzarossa E, Bettoli V, Caproni M, Scocco GL, Bonci A, Bencini P, Naldi L: Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012.
• [9]Zouboulis C, Nestoris S, Adler YD, Orth M, Orfanos CE, Picardo M, Camera E, Cunliffe WJ: A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 2003, 139:668-670.
• [10]Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, Schindler R, Dinarello C: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.
• [11]Meydani S, Endres S, Woods MM, Barry R, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL: Oral (n-3) fatty acids supplementation suppresses cytokine production and lymphocyte proliferation: comparison between younger and older women. J Nutr 1991, 121:547-555.
• [12]Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ: The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oils or fish oil. Am J Clin Nutr 1996, 62:116-122.
• [13]Rubin MG, Kim K, Logan AC: Acne vulgaris, mental health and omega-3 fatty acids: a report of cases. Lipids Health Dis 2008, 7:36. BioMed Central Full Text
• [14]Arican O, Kurutas EB, Sasmaz S: Oxidative stress in patients with acne vulgaris. Mediat Inflamm 2005, 14:308-384.
• [15]Basak PY, Glutekin F, Kilinc I: The role of antioxidative defense system in paupopustular acne. J Dermatol 2001, 28:123-127.
• [16]El-Akawai Z, Abdel-Latif N, Abdul-Razzak K: Does the plasma level of vitamins A and E affect acne condition? Clin Exp Dermatol 2006, 31:430-434.
• [17]Dreno B, Foulic P, Reymaud A, Moyse D, Habert H, Richet H: Effects of zinc gluconate on propionibacterium acnes resistanceto erythromycin in patient with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005, 15:152-155.
• [18]Allen BS, Smith JG: Various parameters for grading acne vulgaris. Arch Dermatol 1982, 118:22-25.
• [19]Centers for Disease Control and Prevention Database. http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html webcite
• [20]Healy ZR, Dinkova-Kostova AT, Wehage SL, Thompson RE, Fahey JW, Talalay P: Precise determination of the erythema response of human skin to ultraviolet radiation and quantification of effects of protectors. Photodermatol Photoimmunol Photomed 2009, 25:45-50.
• [21]Clarys P, Alewaeters K, Lambrecht R, Barel AO: Skin color measurements: comparison between three instruments: the Chromameter, the DermaSpectrometer, and the Mexameter. Skin Res Technol 2000, 6:230-238.
• [22]Lee DH, Li K, Suh DH: Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial. Br J Dermatol 2008, 158:1069-1076.
• [23]Hoffmann K, Dirschka T, Schwarze H, Stucker M, El-Gammal S, Hoffmann A, Altmeyer P: Non-invasive evaluation of inflammation in atopic dermatitis. J Eur Acad Dermatol Venereol 1994, 3:347-353.
• [24]Cleland LG, James MJ: Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits. J Rheumatol 2000, 27:2305-2307.